Molecular Biology RNA Therapies 
Drug Target Review
JULY 11, 2025
From maths and physics to molecular biology Schnall-Levin did not begin in the life sciences. “I I started looking around and getting interested in biology. I got my eyes opened to molecular biology, bioinformatics, computational biology and these emerging fields at the time.”
Alta Sciences
JULY 9, 2025
Altasciences at ASGCT 2025: An Open Forum for All Things Gene and Cell Therapy | By Kaylyn Koenig aasimakopoulos Thu, 07/10/2025 - 08:00 I recently returned from attending the American Society of Gene and Cell Therapy (ASGCT) Annual Meeting. WHO WAS AT ASGCT 2025?
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Codon
JUNE 5, 2025
The treatment, now known as Casgevy, became the first CRISPR-based therapy to gain FDA approval, in 2023. The core of the CRISPR immune response is a guide RNA (gRNA) that binds to a CRISPR-associated (Cas) protein. Collectively, these repeat-protospacer regions are known as CRISPR arrays. Visit our website to get a copy.
Codon
NOVEMBER 1, 2024
I’ve chosen these two because I think they are the linchpin by which we’ll be able to build broadly useful AI models for cell and molecular biology. Scientists are already building a model that can, for example, look at which RNA molecules are expressed in a cell at t=0 and predict how those molecules will change at t=1.
Broad Institute
JUNE 25, 2025
The scientists suggest that new therapies that target these genes could directly address fibrosis and potentially be more effective for this complication than existing drugs, which are primarily focused on reducing inflammation. But now we can potentially think about additive therapies that more directly target the fibrotic process.”
Broad Institute
OCTOBER 23, 2024
In recent years, genetic editing technologies and other gene therapy approaches have given scientists the ability to alter the genes inside living cells. This limits our ability to design gene therapies that only effect certain cell types in the human body." Chan School of Public Health. "By
DrugBank
MAY 15, 2024
But as molecular biology has advanced, so too has our approach to finding new drugs. Another promising avenue is the use of technologies like RNA interference and gene editing, which allow scientists to turn off the production of certain proteins altogether. This method was more about serendipity than science.
Expert insights. Personalized for you.
69 
Let's personalize your content